1. Thymopoietin to thymopentin: experimental studies

   • Gideon Goldstein
   • Tapan K. Audhya

   OriginalPaper Pages: 1 - 10

2. Thymopentin structure and relation to thymic factors

   • George A. Heavner

   OriginalPaper Pages: 11 - 16

3. Thymopentin: stability considerations and potency by various routes of administration

   • T. K. Audhya
   • G. Goldstein

   OriginalPaper Pages: 17 - 23

4. Herpes simplex clinical and pathogenetic aspects

   • Sture Lidén

   OriginalPaper Pages: 24 - 29

5. Thymopentin treatment of herpes simplex infections

   • J. DeMaubeugea
   • E. Hanekeb
   • K. Bollaj

   OriginalPaper Pages: 30 - 36

6. Prevention of recurrences in frequently relapsing herpes labialis with thymopentin a randomized double-blind placebo-controlled multicenter study

   • K. Bolla
   • D. Djawari
   • E. Sundal

   OriginalPaper Pages: 37 - 47

7. Effect of thymopentin on the mortality and immune response after an experimental herpes simplex infection in mice

   • R. Cappel
   • F. de Cuyper
   • K. Bolla

   OriginalPaper Pages: 48 - 57

8. Thymopentin treatment in aids and pre-aids patients

   • N. Clumeck
   • S. Cran
   • K. Bolla

   OriginalPaper Pages: 58 - 62

9. Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy

   • A. Castells
   • J. Terencio
   • K. Bollac

   OriginalPaper Pages: 63 - 69

10. Rationale for thymopentin as therapeutic agent in rheumatoid arthritis

    • P. Franchirnont
    • K. Bolla

    OriginalPaper Pages: 70 - 75

11. Some observations on various dose regimens of thymopentin treatment in rheumatoid arthritis

    • L. Moling
    • F. Schmid
    • K. Bolla

    OriginalPaper Pages: 76 - 80

12. Thymopentin in active rheumatoid arthritis

    • P. Franchimont
    • C. Hauwaert
    • K. Bolla

    OriginalPaper Pages: 81 - 86

13. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis

    • M. Malaise
    • P. Franchimont
    • K. Bolla

    OriginalPaper Pages: 87 - 93

14. Modulation of immune response in aged humans through different administration modes of thymopentin

    • J. Duchateau
    • G. Servais
    • K. Bolla

    OriginalPaper Pages: 94 - 101

15. Thymopentin as adjuvant therapy to hepatitis B Vaccination in formerly non- or hyporesponding hemodialysis patients

    • K. Zàmba
    • P. J. Grob
    • K. Bolla

    OriginalPaper Pages: 102 - 106

16. Thymopentín as adjuvant to hepatitis vaccination

    • P. J. Grob
    • U. Binswanger
    • K. Bolla

    OriginalPaper Pages: 107 - 115

17. In vitro influence of thymopentin on proliferative responses and phytohemagglutinin-induced interleukin 2 production in normal human lymphocyte cultures

    • J. Duchateau
    • G. Servais
    • K. Bolla

    OriginalPaper Pages: 116 - 124

18. Thymopentin treatment in a patient with pluriorifieial Pyoderma vegetans

    • M. Simon
    • D. Djawari
    • K. Bolla

    OriginalPaper Pages: 125 - 128

19. Thymopeníin treatment of selective IgA deficiency

    • M. Fiorilli
    • I. Quinti
    • F. Aiuti

    OriginalPaper Pages: 129 - 134

20. Thymopentin in chronicTrichophyton rubrum infection

    • L. Molin
    • K. Bolla

    OriginalPaper Pages: 135 - 138

21. Thymopentin: Safety overview

    • N. Friedmann

    OriginalPaper Pages: 139 - 148

22. Safety of thymopentin

    • P. Weiss
    • H. Stocker

    OriginalPaper Pages: 149 - 154